Tamsin Rm Lannagan

7PUBLICATIONS

107CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|May 26, 2026

Viral mimicry redirects immunosuppressed colorectal tumour landscapes towards a proinflammatory and CMS1-like regenerative state.

|Nov 25, 2025

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance.

Mark White, Megan L Mills, Laura M Millett

|Feb 10, 2025

Oncofetal reprogramming drives phenotypic plasticity in WNT-dependent colorectal cancer.

Slim Mzoughi, Megan Schwarz, Xuedi Wang

|Jan 02, 2025

Enterocyte-like differentiation defines metabolic gene signatures of CMS3 colorectal cancers and provides therapeutic vulnerability.

Arezo Torang, Aleksandar B Kirov, Veerle Lammers

|Aug 09, 2024

Epigenetic and Oncogenic Inhibitors Cooperatively Drive Differentiation and Kill KRAS-Mutant Colorectal Cancers.

Patrick Loi, Amy E Schade, Carrie L Rodriguez

|Mar 17, 2024

Noninvasive Stratification of Colon Cancer by Multiplex PET Imaging.

Gaurav Malviya, Tamsin R M Lannagan, Emma Johnson

Pageof 2

Frequent Collaborators

Owen Sansom

Andrew D Campbell

Kathryn Gilroy

Colin Nixon

Rene Jackstadt

Raheleh Amirkhah

Philip D Dunne

Mark White

Megan L Mills

Rachel A Ridgway

Frequent Collaborators

Owen Sansom

Andrew D Campbell

Kathryn Gilroy

Colin Nixon